These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38342375)

  • 1. Synergistic therapeutic strategies and engineered nanoparticles for anti-vascular endothelial growth factor therapy in cancer.
    Khafaga AF; Gaballa MMS; Karam R; Shoulah SA; Shamma RN; Khalifa NE; Farrag NE; Noreldin AE
    Life Sci; 2024 Mar; 341():122499. PubMed ID: 38342375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Targeting H
    Jung E; Lee J; Lee Y; Seon S; Park M; Song C; Lee D
    ACS Appl Bio Mater; 2021 May; 4(5):4450-4461. PubMed ID: 35006857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update.
    Ghasemali S; Farajnia S; Barzegar A; Rahmati-Yamchi M; Baghban R; Rahbarnia L; Nodeh HRY
    Anticancer Agents Med Chem; 2021; 21(1):3-19. PubMed ID: 32807068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S; Rich JN
    Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
    Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
    Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Drugs with High Efficacy against Tumor Angiogenesis.
    Qi S; Deng S; Lian Z; Yu K
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
    Wilson PM; LaBonte MJ; Lenz HJ
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic inhibitors: a new therapeutic strategy in oncology.
    Gasparini G; Longo R; Toi M; Ferrara N
    Nat Clin Pract Oncol; 2005 Nov; 2(11):562-77. PubMed ID: 16270097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
    Butler CT; Reynolds AL; Tosetto M; Dillon ET; Guiry PJ; Cagney G; O'Sullivan J; Kennedy BN
    J Biol Chem; 2017 Mar; 292(9):3552-3567. PubMed ID: 28035003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer.
    Mukherjee A; Madamsetty VS; Paul MK; Mukherjee S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study.
    Lattanzio R; La Sorda R; Facciolo F; Sioletic S; Lauriola L; Martucci R; Gallo E; Palmieri G; Evoli A; Alessandrini G; Ruco L; Rendina EA; Truini M; Chiarle R; Barreca A; Pich A; Ascani S; Remotti D; Tunesi G; Granone P; Ratto GB; Puma F; Pescarmona E; Piantelli M; Marino M; ; Carlini S; Cerasoli V; Corzani F; Melis E; Filippetti M; Canalini P; Palestro G; Lalle M; Ruffini E; Ceribelli A; Rinaldi M
    Lung Cancer; 2014 Aug; 85(2):191-6. PubMed ID: 24908332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
    Welti J; Loges S; Dimmeler S; Carmeliet P
    J Clin Invest; 2013 Aug; 123(8):3190-200. PubMed ID: 23908119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine.
    Alsaab HO; Al-Hibs AS; Alzhrani R; Alrabighi KK; Alqathama A; Alwithenani A; Almalki AH; Althobaiti YS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF.
    Ghalehbandi S; Yuzugulen J; Pranjol MZI; Pourgholami MH
    Eur J Pharmacol; 2023 Jun; 949():175586. PubMed ID: 36906141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy.
    Yadav P; Dua C; Bajaj A
    Chem Rec; 2022 Dec; 22(12):e202200152. PubMed ID: 36103616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.
    Annan DA; Kikuchi H; Maishi N; Hida Y; Hida K
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new drugs in angiogenesis.
    Ziche M; Donnini S; Morbidelli L
    Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.